These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis. Cui FB; Lv X; Yan CL; Eng WS; Yu SY; Zheng QH Ann Nucl Med; 2024 Apr; 38(4):247-263. PubMed ID: 38145430 [TBL] [Abstract][Full Text] [Related]
8. On the Optimization of the Protocol for Automated Radiosyntheses of [ Menon SR; Mitra A; Sahu S; Lad S; Chakraborty A; Ray MK; Banerjee S Asia Ocean J Nucl Med Biol; 2024; 12(2):149-160. PubMed ID: 39050235 [TBL] [Abstract][Full Text] [Related]
9. Microfluidic-based production of [ Mallapura H; Ovdiichuk O; Jussing E; Thuy TA; Piatkowski C; Tanguy L; Collet-Defossez C; Långström B; Halldin C; Nag S EJNMMI Radiopharm Chem; 2023 Dec; 8(1):42. PubMed ID: 38091157 [TBL] [Abstract][Full Text] [Related]
10. Optimization of Cankaya A; Balzer M; Amthauer H; Brenner W; Spreckelmeyer S EJNMMI Radiopharm Chem; 2023 May; 8(1):10. PubMed ID: 37233924 [TBL] [Abstract][Full Text] [Related]
11. One-pot and one-step automated radio-synthesis of [ Naka S; Watabe T; Lindner T; Cardinale J; Kurimoto K; Moore M; Tatsumi M; Mori Y; Shimosegawa E; Valla F; Kato H; Giesel FL EJNMMI Radiopharm Chem; 2021 Aug; 6(1):28. PubMed ID: 34420105 [TBL] [Abstract][Full Text] [Related]
12. Fully-automated production of [ Spreckelmeyer S; Schulze O; Brenner W EJNMMI Radiopharm Chem; 2020 Feb; 5(1):8. PubMed ID: 32107654 [TBL] [Abstract][Full Text] [Related]
13. A practical fully automated radiosynthesis of [ Eryilmaz K; Kilbas B EJNMMI Radiopharm Chem; 2022 Nov; 7(1):30. PubMed ID: 36334143 [TBL] [Abstract][Full Text] [Related]
16. Development of a versatile [ Paty LP; Degueldre S; Provost C; Schmitt C; Trump L; Fouque J; Vriamont C; Valla F; Gendron T; Madar O Front Chem; 2024; 12():1411312. PubMed ID: 39076612 [TBL] [Abstract][Full Text] [Related]
17. Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131. De Decker M; Turner JH Cancer Biother Radiopharm; 2012 Feb; 27(1):72-6. PubMed ID: 22149590 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein targeted therapy using [ Liu Y; Watabe T; Kaneda-Nakashima K; Shirakami Y; Naka S; Ooe K; Toyoshima A; Nagata K; Haberkorn U; Kratochwil C; Shinohara A; Hatazawa J; Giesel F Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):871-880. PubMed ID: 34537893 [TBL] [Abstract][Full Text] [Related]
19. Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy. Zhang P; Xu M; Ding J; Chen J; Zhang T; Huo L; Liu Z Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1985-1996. PubMed ID: 34746969 [TBL] [Abstract][Full Text] [Related]
20. Lutetium-177 DOTATATE Production with an Automated Radiopharmaceutical Synthesis System. Aslani A; Snowdon GM; Bailey DL; Schembri GP; Bailey EA; Pavlakis N; Roach PJ Asia Ocean J Nucl Med Biol; 2015; 3(2):107-15. PubMed ID: 27408890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]